These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6393865)

  • 1. Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.
    Falkowski AJ; Creger RJ
    Antimicrob Agents Chemother; 1984 Nov; 26(5):643-6. PubMed ID: 6393865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.
    Konishi H; Goto M; Nakamoto Y; Yamamoto I; Yamashina H
    Antimicrob Agents Chemother; 1983 May; 23(5):653-7. PubMed ID: 6223576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
    Pickering LK; Rutherford I
    J Pharmacol Exp Ther; 1981 May; 217(2):345-9. PubMed ID: 6453219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
    Watanakunakorn C
    J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.
    Hale DC; Jenkins R; Matsen JM
    Am J Clin Pathol; 1980 Sep; 74(3):316-9. PubMed ID: 6447998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin.
    Henderson JL; Polk RE; Kline BJ
    Am J Hosp Pharm; 1981 Aug; 38(8):1167-70. PubMed ID: 6455916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lack of inactivation of tobramycin by cefazolin, cefamandole, and moxalactam in vitro.
    Earp CM; Barriere SL
    Drug Intell Clin Pharm; 1985 Sep; 19(9):677-9. PubMed ID: 4042863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of EMIT versus bioassay to evaluate inactivation of tobramycin by piperacillin.
    Anders RJ; Lau A; Sharifi R; Lee M
    Ther Drug Monit; 1987 Dec; 9(4):472-7. PubMed ID: 3321583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo inactivation of gentamicin by carbenicillin and ticarcillin.
    Kradjan WA; Burger R
    Arch Intern Med; 1980 Dec; 140(12):1668-70. PubMed ID: 7458498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
    Reimer LG; Mirrett S; Reller LB
    Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring.
    Tindula RJ; Ambrose PJ; Harralson AF
    Drug Intell Clin Pharm; 1983 Dec; 17(12):906-8. PubMed ID: 6653408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of experimental tobramycin nephrotoxicity by ticarcillin.
    English J; Gilbert DN; Kohlhepp S; Kohnen PW; Mayor G; Houghton DC; Bennett WM
    Antimicrob Agents Chemother; 1985 Jun; 27(6):897-902. PubMed ID: 4026263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
    Gwynn MN; Rolinson GN
    Infection; 1980; 8(2):73-80. PubMed ID: 6771215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inactivation of tobramycin by cephalosporins.
    Spruill WJ; McCall CY; Francisco GE
    Am J Hosp Pharm; 1985 Nov; 42(11):2506-9. PubMed ID: 3907338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin.
    Pickering LK; Gearhart P
    Antimicrob Agents Chemother; 1979 Apr; 15(4):592-6. PubMed ID: 464591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism of azlocillin, mezlocillin, piperacillin in combination with tobramycin against Klebsiella and Pseudomonas.
    Downs JT; Andriole VT; Ryan JL
    Yale J Biol Med; 1986; 59(1):11-6. PubMed ID: 3634545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inactivation of tobramycin by penicillins.
    Rank DM; Packer AM; Tierney MG
    Am J Hosp Pharm; 1984 Jun; 41(6):1187-8. PubMed ID: 6741967
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
    Dibb WL; Asphaug Kjellevold V; Digranes A
    Chemotherapy; 1983; 29(5):332-6. PubMed ID: 6311491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.